Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Tipo de documento
Intervalo de ano de publicação
1.
Scand J Gastroenterol ; 49(4): 485-91, 2014 04.
Artigo em Inglês | MEDLINE | ID: mdl-24495046

RESUMO

OBJECTIVE: Currently available preparations for colonoscopy have low tolerability and may cause fluid and electrolyte shifts. An alternative method of bowel cleansing is required. MATERIAL AND METHODS: Preparation of the gut using oral nutritional supplements (ONS) and rectal enema was tested as an alternative method of bowel cleansing. During 2008-2012, patients were randomized to oral nutritional supplements (n = 27) for 5 days and rectal enema or polyethylene glycol (PEG) (n = 23) prior to colonoscopy. Blinded endoscopists rated the degree of bowel cleansing according to the Ottawa bowel preparation scale (OBS) (primary outcome). Tolerability of either preparation was also assessed RESULTS: Due to a high rate of bowel cleansing failure among patients receiving ONS, the study was interrupted prematurely. Colonoscopies were incomplete due to stools in 6 of 27 patients in the ONS group compared to 1 of 23 in the PEG group (ns). The mean total OBS were 8.3 ± 3.3 and 5.3 ± 2.8, respectively (p = 0.002). Four patients (15%) in the ONS group and eight patients (35%) receiving PEG had an OBS score ≤4 (good preparation) (ns). ONS was better tolerated than PEG with more patients reporting acceptable taste (27 of 27 [100%] vs. 15 of 23 [65%], p = 0.001), and fewer reporting difficulties with the intake (0 of 27 [0%] vs. 10 of 23 [43%], p < 0.001) and nausea (5 of 27 [19%] vs. 13 of 23 [57%], p < 0.008). CONCLUSIONS: For routine use, ONS with enema instead of traditional preparation for colonoscopy with PEG cannot be generally recommended.


Assuntos
Colonoscopia , Proteínas Alimentares/uso terapêutico , Enema , Polietilenoglicóis/uso terapêutico , Adulto , Idoso , Idoso de 80 Anos ou mais , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Projetos Piloto , Suécia
2.
Int J Vitam Nutr Res ; 78(4-5): 183-94, 2008.
Artigo em Inglês | MEDLINE | ID: mdl-19326341

RESUMO

The protective effect of vitamin E supplements has been questioned, possibly because they often contain only alpha-tocopherol, and recent studies indicate that gamma-tocopherol also has important properties. The aim of this study was to investigate whether the levels of DNA lesions in middle-aged, overweight males could be reduced by consumption of low doses of an antioxidant supplement for six weeks, designed to imitate a balanced diet. The participants (n=60) were randomly divided into: placebo, single-, and double-dose groups. Genotoxic and oxidative DNA lesions in mononuclear cells were measured with the Comet assay, before and after supplement administration. Furthermore, a cell study was performed to investigate if pre-incubation of a human lung cell line (A549) with alpha- and gamma-tocopherol (5 and 50 microM for 23 hours) could protect against induced oxidative DNA lesions as measured by the Comet assay. The level of oxidative DNA lesions in the double-dose group was significantly lower than in the control group. Oxidative DNA lesions correlated only to changes in serum gamma-tocopherol, and not alpha-tocopherol. In the cell study, only gamma-tocopherol protected cells against induced oxidative DNA lesions. We therefore hypothesize that gamma-tocopheol rather than alpha-tocopherol is involved in reducing oxidative DNA lesions.


Assuntos
Antioxidantes/farmacologia , Dano ao DNA/efeitos dos fármacos , Leucócitos Mononucleares/efeitos dos fármacos , Magnoliopsida , Extratos Vegetais/farmacologia , alfa-Tocoferol/farmacologia , gama-Tocoferol/farmacologia , Adulto , Linhagem Celular , Ensaio Cometa , Suplementos Nutricionais , Regulação para Baixo/efeitos dos fármacos , Frutas , Humanos , Masculino , Pessoa de Meia-Idade , Sobrepeso/tratamento farmacológico , Fitoterapia , Verduras , alfa-Tocoferol/sangue , gama-Tocoferol/sangue
3.
Diabetes Care ; 29(7): 1471-7, 2006 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-16801564

RESUMO

OBJECTIVE: The effect of exercise training and acarbose on glycemic control, insulin sensitivity, and phenotype was investigated in mild type 2 diabetes. RESEARCH DESIGN AND METHODS: Sixty-two men and women with type 2 diabetes were randomized to 12 weeks of structured exercise training with or without acarbose treatment or to acarbose alone. Glycemic control was determined by HbA(1c) (A1C), insulin sensitivity (M value) by euglycemic-hyperinsulinemic clamp, and regional fat distribution by computerized tomography and dual X-ray absorptiometry. Physical fitness was determined as maximal oxygen uptake (Vo(2max)). All investigations were performed before and after the intervention. RESULTS: Forty-eight subjects completed the study. Exercise improved M value by 92% (P = 0.017) and decreased total and truncal fat (P = 0.002, 0.001) and systolic blood pressure (P = 0.01) but had no significant effect on Vo(2max) or A1C level. The combination of exercise and acarbose significantly decreased fasting plasma glucose, A1C, lipids, and diastolic blood pressure and increased Vo(2max), whereas effects on M value and body composition were comparable with that of exercise alone. Acarbose alone had no significant effect on either M value or A1C but decreased systolic (P = 0.001) and diastolic blood pressure (P = 0.001) and fasting proinsulin level (P = 0.009). Multiple regression analysis showed that addition of acarbose to exercise improved glycemic control. CONCLUSIONS: In subjects with mild type 2 diabetes, exercise training improved insulin sensitivity but had no effect on glycemic control. The addition of acarbose to exercise, however, was associated with significant improvement of glycemic control and possibly cardiovascular risk factors.


Assuntos
Acarbose/uso terapêutico , Glicemia/metabolismo , Doenças Cardiovasculares/etiologia , Diabetes Mellitus Tipo 2/terapia , Exercício Físico/fisiologia , Hipoglicemiantes/uso terapêutico , Apolipoproteínas/sangue , Pressão Sanguínea , Feminino , Humanos , Resistência à Insulina/fisiologia , Lipídeos/sangue , Masculino , Pessoa de Meia-Idade , Inibidor 1 de Ativador de Plasminogênio/sangue , Fatores de Risco
4.
Diabetes ; 52(6): 1377-85, 2003 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-12765947

RESUMO

To determine the in vivo effect of amino acids (AAs) alone or in combination with insulin on splanchnic and muscle protein dynamics, we infused stable isotope tracers of AAs in 36 healthy subjects and sampled from femoral artery and vein and hepatic vein. The subjects were randomized into six groups and were studied at baseline and during infusions of saline (group 1), insulin (0.5 mU. kg(-1). min(-1)) (group 2), insulin plus replacement of AAs (group 3) insulin plus high-dose AAs (group 4), or somatostatin and baseline replacement doses of insulin, glucagon and GH plus high dose of AAs (group 5) or saline (group 6). Insulin reduced muscle release of AAs mainly by inhibition of protein breakdown. Insulin also enhanced AA-induced muscle protein synthesis (PS) and reduced leucine transamination. The main effect of AAs on muscle was the enhancement of PS. Insulin had no effect on protein dynamics or leucine transamination in splanchnic bed. However, AAs reduced protein breakdown and increased synthesis in splanchnic bed in a dose-dependent manner. AAs also enhanced leucine transamination in both splanchnic and muscle beds. Thus insulin's anabolic effect was mostly on muscle, whereas AAs acted on muscle as well as on splanchnic bed. Insulin achieved anabolic effect in muscle by inhibition of protein breakdown, enhancing AA-induced PS, and reducing leucine transamination. AAs largely determined protein anabolism in splanchnic bed by stimulating PS and decreasing protein breakdown.


Assuntos
Aminoácidos/farmacologia , Glicemia/metabolismo , Proteínas Sanguíneas/metabolismo , Insulina/farmacologia , Proteínas Musculares/metabolismo , Músculo Esquelético/metabolismo , Circulação Esplâncnica/fisiologia , Adulto , Aminoácidos/administração & dosagem , Glicemia/efeitos dos fármacos , Proteínas Sanguíneas/efeitos dos fármacos , Índice de Massa Corporal , Glucagon/sangue , Homeostase/efeitos dos fármacos , Hormônio do Crescimento Humano/sangue , Humanos , Hidrocortisona/sangue , Infusões Intravenosas , Insulina/administração & dosagem , Proteínas Musculares/efeitos dos fármacos , Músculo Esquelético/efeitos dos fármacos , Valores de Referência , Circulação Esplâncnica/efeitos dos fármacos
6.
Atherosclerosis ; 161(2): 327-33, 2002 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-11888515

RESUMO

OBJECTIVE: A high fat diet contributes to obesity and acutely impairs endothelium dependent vasorelaxation. While a high cholesterol diet chronically impairs endothelium dependent vasorelaxation in rabbits, this model is associated with severe hypercholesterolemia. The effect of chronic high fat feeding on endothelial function in the setting of more normal lipid levels has not been studied. Our aim was to study vascular function in rats overfed for 6 months and to determine the role of oxidative stress in the alteration of vascular function associated with this diet. METHODS: Forty-five male Sprague-Dawley rats were placed on the following diets for 6 months, control diet, high fat diet or high fat diet supplemented with vitamins A, E and selenium. Six months later blood samples were collected and vascular function was assessed in the aorta. RESULTS: The rats fed a high fat diet were heavier than controls (608.4 +/- 41.8 vs. 700.3 +/- 50.1 vs. 699.5 +/- 52.6 g, P<0.05 for control vs. high fat and high fat plus antioxidant groups) but lipid levels were similar in each group (cholesterol, 145.9 +/- 53.4 vs. 140.5 +/- 44.0 vs. 152.7 +/- 36.1 mg/dl and triglycerides, 173.2 +/- 106.7 vs. 197.4 +/- 131.3 vs. 166.1 +/- 65.3 mg/dl, P, NS). Relaxations to acetylcholine and calcium were significantly impaired in the high fat diet group compared with controls (EC(50), 6.90 +/- 0.22, 7.12 +/- 0.32; AUC, 96.9 +/- 51.6, 155.5 +/ - 73.7) but were not different between the antioxidant supplemented group and controls (EC(50), 7.06 +/- 0.37; AUC, 151.9 +/- 67.4). Relaxations to DEA NONOate were similar in each group. CONCLUSIONS: Dietary antioxidants preserved endothelium dependent vasorelaxation in rats fed a high fat diet for 6 months.


Assuntos
Antioxidantes/farmacologia , Gorduras na Dieta/administração & dosagem , Óxido Nítrico/metabolismo , Vasodilatação/efeitos dos fármacos , Análise de Variância , Animais , Glicemia/análise , Western Blotting , Dieta Aterogênica , Modelos Animais de Doenças , Endotélio Vascular/efeitos dos fármacos , Endotélio Vascular/fisiologia , Masculino , Probabilidade , Ratos , Ratos Sprague-Dawley , Valores de Referência , Selênio/farmacologia , Vasodilatação/fisiologia , Vitamina A/farmacologia , Vitamina E/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA